San Francisco, April 20, 2016 -- The Vitamin D Testing market is estimated to reach at more than CAGR of 32.35% from 2013 to 2018. The major reason for the development of this market is the increase in the geriatric population and chronic illness globally. The vitamin D testing market is observing approval for the increase in the products. Nevertheless, requirement for strict rules can present confront to the raise of the market.
Browse Full Research Report With TOC on http://www.radiantinsights.com/research/global-vitamin-d-testing-market-2014-2018
The market is estimated to observe a stable growth in the future. The viewpoint for the development of the market depends on features including major incidence of vitamin D shortage in the people resulting into moderate but slow growth of the market. The avoidance of different chronic and acute sickness is the major driver for the vitamin D testing market growth.
Chronic sicknesses like osteoporosis and rickets can occur due to deficiency of vitamin D. Vitamin D deficiency can also lead to asthma in infants, cardiovascular diseases, cognitive disorder, autoimmune diseases, and cancer. Frequent checking of the level of vitamin D in the body can reduce the occurrence of these diseases. This would in turn lower the overall expenditure related to healthcare.
See More Reports of This Category by Radiant Insights: www.radiantinsights.com/catalog/healthcare
The 25-Hydroxy vitamin D tests & 1, 25-Dihydroxy vitamin test sectors are estimated to be the largest market sector over the forecast period. At present this market sector holds a share of over three forth of the total market and is estimated to remain dominant over the forecast period. The capability of 25-Hydroxy vitamin D test has significant role in identifying bone weakness, bone softness & malfunction, or fracture in adult which is estimated to result in high share of the market over the forecast phase.
The market is extremely cutthroat and has companies focusing on research and development of tests. These companies compete on the ground of quality, product line width, price, technology, & distribution ability to get maximum importance in the market.
Get Sample Report Copy @ www.radiantinsights.com/research/global-vitamin-d-testing-market-2014-2018#tabs-4
The major companies in this market include Roche Diagnostics, Siemens Healthcare Diagnostics, Abbott Diagnostics, Quest Diagnostics, and Biomeriux Diasorin. Vitamin D testing kit at homes is gaining fame being highly price efficient.
Explore Other Reports By Radiant Insights,Inc at
- Butyl Acetate Markets –
http://www.radiantinsights.com/research/butyl-acetate-markets-in-china
- Cyanuramide Markets –
http://www.radiantinsights.com/research/cyanuramide-markets-in-china
About Radiant Insights
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy.Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Web: http://www.radiantinsights.com/


Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



